ParkerVision FY 2025 net loss narrows 49% to USD 7 million on USD 4 million cash`

Reuters
Mar 24
ParkerVision FY 2025 net loss narrows 49% to USD 7 million on USD 4 million cash`
  • ParkerVision published a press release reporting full-year 2025 results, posting a net loss of USD 7.4 million, or USD 0.06 per share.
  • The net loss narrowed 48.69% from the prior year, driven mainly by a USD 570,000 gain from changes in the fair value of contingent payment obligations.
  • Selling, general and administrative expenses rose 78.45% to USD 7.6 million, including a USD 2.5 million one-time noncash share-based compensation charge tied to extending option expirations.
  • Cash and cash equivalents were USD 4.4 million at year-end, while net cash used in operating activities was USD 5.1 million.
  • On business updates, the Qualcomm appeal received an expedited CAFC schedule with briefings completed by March 23, 2026, while the first MediaTek patent trial in Texas was postponed pending updated expert reports and related briefings.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ParkerVision Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 202603231601ACCESSWRNAPR_____1150764) on March 23, 2026, and is solely responsible for the information contained therein.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10